Connect
← Return to Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors
Discussion
Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors
Neuroendocrine Tumors (NETs) | Last Active: Jul 25, 2023 | Replies (14)Comment receiving replies
Researchers are studying Ivermectin to see if it may be used as an anti-cancer drug and early studies show promise. Please note that this research is in the early stages (mice studies) and has not yet been tested in human trials. Ivermectin is not a proven standard treatment for prostate cancer.
Ivermectin combined with other chemotherapy drugs or targeted drugs is being studied in early clinical trials and shows promise in patients for whom conventional chemotherapy has not worked in some cancer types. It may be effective against drug-resistant cancer cells.
– Ivermectin, a potential anticancer drug derived from an antiparasitic drug https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
@mpuap, do you have further studies showing efficacy of ivermectin with other cancer drugs? Are you on a clinical trial?
Replies to "Researchers are studying Ivermectin to see if it may be used as an anti-cancer drug and..."
Connect
Unfortunately there are no trials with my rare cancer. No data on treatment so everything is a trial of sorts. No money in rare stuff. I’m also using Lycopene, quercetin and Curcumin in a rational cycle relative to chemo. Hope to develop a protocol of sorts for treatment for this cancer as the limited data appears to indicate 4.8 months median period for dx to dead. My initial pathology was in January of this year with pet scan confirmation of stage 4 in April. FOLFOX started 5/9. Just received second round of Pembrolizumab plus 5-FU/Lv today. Dosing ivermectin at 0.4mg/kg days 1-3 each week. Any additional info would be appreciated eve is anecdotal. Cheers!